Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cinacalcet for secondary hyperparathyroidism in pediatric patients
2009-016797-32Phase 2Active
- Sponsor
- Istituto Giannina Gaslini
- Start
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of cinacalcet in secondary hyperparathyroidism (SHPT), sponsored by Istituto Giannina Gaslini. Primary endpoint: Primary efficacy endpoint. Started Nov 2009; status: active.
02
Drugs
cinacalcet
03
Conditions
secondary hyperparathyroidism (SHPT)
Beyond the preview
Go deeper on 2009-016797-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016797-32.